DreaMed

Petah Tikva, Israel · Founded 2014 · Privately Held (backing)

Developer of a diabetes management system designed to optimize intensive insulin therapy. DreaMed is based in Petah Tikva, Israel and was founded in 2014. It has raised $9.5 million.

Last price · $/share
—
Implied valuation
—
Total raised
$9.5M
Last round
—

Who backs DreaMed?

10 investors
InvestorType
OurCrowdOther
The Leona M. and Harry B. Helmsley Charitable TrustOther
Roman AbramovichOther
A-Labs—
Mark Suss—
Medtronic—
National Institute of Diabetes and Digestive and Kidney Diseases—
StartUp Health—
The Millhouse—
eHealth Ventures (Israel)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

DreaMed investors

10 investors are on record for DreaMed, including OurCrowd, The Leona M. and Harry B. Helmsley Charitable Trust, Roman Abramovich and A-Labs.

Free account
More of DreaMed with a free account
  • ·Watch DreaMed: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like DreaMed. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View